Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MTPC Aims at Restoring Public's Confidence, Developing Global Products: New President-elect Dr Tsuchiya
May 18, 2009
- R&D NEWS IN BRIEF
May 18, 2009
- Japan Provides High-Quality Data in Multinational Trials: Prof. Sato
May 18, 2009
- JPMA to Support Development of 14 Unapproved Drugs
May 18, 2009
- Nichi-Iko Opens New Office in Tokyo
May 18, 2009
- MTPC Holds Event to Promote Use of Generics
May 18, 2009
- Original Drugs Should Give Way to Generics when They Go Off-Patent: Mr Kinoshita
May 18, 2009
- BI Records Growth Rates Higher than Industry Average for 9th Year Running
May 18, 2009
- REGULATORY NEWS IN BRIEF
May 18, 2009
- Additional Indications to Be Approved for Nexavar, Valixa, Alimta
May 18, 2009
- Questions Raised on Approval of Caduet: CDFS
May 18, 2009
- Hospitals Should Not Use In-House Prescriptions to Obtain Yakkasa
May 18, 2009
- BUSINESS NEWS IN BRIEF
May 18, 2009
- Highlights of 97th JUA Annual Meeting
May 18, 2009
- IMS Proposes Shift of Focus to Emerging Markets
May 18, 2009
- Applied Therapeutics Society Inaugurated
May 18, 2009
- Alfresa to Reduce SGA Cost Ratio to 5-5.5%
May 18, 2009
- Survey Reveals Low Awareness Rates for OTC Drugs, Self-Medication
May 18, 2009
- Price Settlement Rate Stood at 98% as of the End of FY2008
May 18, 2009
- BUSINESS NEWS IN BRIEF
May 4, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…